Clinical trials
Observational Immunoglobulin Light-chain Amyloidosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2007 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 6 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Cleveland Clinic | 3 |
| Tufts Medical Center | 3 |
| Boston Medical Center | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| Cedars-Sinai Medical Center | 1 |
| City of Hope Medical Center | 1 |
| Mayo Clinic | 1 |
| Midwest Heart & Vascular Specialists | 1 |
| Ohio State University Comprehensive Cancer Center | 1 |
| Prothena Biosciences Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunoglobulin Light-chain Amyloidosis | 19 |
| Multiple Myeloma | 9 |
| Amyloidosis | 7 |
| Waldenstrom Macroglobulinemia | 6 |
| Blast Crisis | 5 |
| Burkitt Lymphoma | 5 |
| Immunoblastic Lymphadenopathy | 5 |
| Intraocular Lymphoma | 5 |
| Leukemia, Biphenotypic, Acute | 5 |
| Leukemia, Hairy Cell | 5 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.